Literature DB >> 22116149

Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients.

Marcus J Zervos1, Katherine Freeman, Lien Vo, Nadia Haque, Hiren Pokharna, Monika Raut, Myoung Kim.   

Abstract

Complicated skin and soft tissue infections (cSSTIs) are among the most rapidly increasing reasons for hospitalization. To describe inpatients with regard to patient characteristics, cSSTI origin, appropriateness of initial antibiotics, and outcomes, we performed a retrospective cohort study in patients hospitalized for cSSTI. To identify independent predictors of outcomes, we performed multivariate analyses. Of 1,096 eligible patients, 48.7% had health care-associated (HCA) cSSTI and 51.3% had community-acquired (CA) cSSTI. After adjustment for baseline variables, hospital length of stay (LOS) was longer for HCA than for CA cSSTI (difference, 2.1 days; 95% confidence interval [CI], 0.8 to 3.5; P < 0.05). Other covariates associated with a longer LOS were need for dialysis (regression coefficient ± standard error, 4.5 ± 1.1) and diabetic wound diagnosis (2.6 ± 1.0) (all P < 0.05). In the subset with culture-positive cSSTI within 24 h of admission, the most common pathogen was Staphylococcus aureus (298/449 [66.4%]), of which 74.8% (223/298) were methicillin-resistant S. aureus (MRSA). Eighty-three patients (18.5%) received inappropriate initial antibiotics. After adjustment for other variables, the following were associated with inappropriate initial therapy: direct admission to hospital (not via emergency department), cSSTI caused by MRSA or mixed pathogens, and cSSTI caused by pathogens other than S. aureus or streptococci (all P < 0.05). We did not find an association between inappropriate therapy and outcomes, except in the subset with ulcers (adjusted odds ratio, 11.8; 95% CI, 1.3 to 111.1; P = 0.03). More studies are needed to examine the impact of HCA cSSTI and inappropriate initial therapy on outcomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116149      PMCID: PMC3264137          DOI: 10.1128/JCM.05817-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Practice guidelines for the diagnosis and management of skin and soft-tissue infections.

Authors:  Dennis L Stevens; Alan L Bisno; Henry F Chambers; E Dale Everett; Patchen Dellinger; Ellie J C Goldstein; Sherwood L Gorbach; Jan V Hirschmann; Edward L Kaplan; Jose G Montoya; James C Wade
Journal:  Clin Infect Dis       Date:  2005-10-14       Impact factor: 9.079

2.  Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.

Authors:  Jörg J Ruhe; Nathaniel Smith; Robert W Bradsher; Anupama Menon
Journal:  Clin Infect Dis       Date:  2007-02-01       Impact factor: 9.079

3.  Methicillin-resistant Staphylococcus aureus disease in three communities.

Authors:  Scott K Fridkin; Jeffrey C Hageman; Melissa Morrison; Laurie Thomson Sanza; Kathryn Como-Sabetti; John A Jernigan; Kathleen Harriman; Lee H Harrison; Ruth Lynfield; Monica M Farley
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

4.  Methicillin-resistant S. aureus infections among patients in the emergency department.

Authors:  Gregory J Moran; Anusha Krishnadasan; Rachel J Gorwitz; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; David A Talan
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

5.  Inappropriate antibiotic use in soft tissue infections.

Authors:  Keyianoosh Z Paydar; Scott L Hansen; Edwin D Charlebois; Hobart W Harris; David M Young
Journal:  Arch Surg       Date:  2006-09

6.  Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008.

Authors:  David A Talan; Anusha Krishnadasan; Rachel J Gorwitz; Gregory E Fosheim; Brandi Limbago; Valerie Albrecht; Gregory J Moran
Journal:  Clin Infect Dis       Date:  2011-07-15       Impact factor: 9.079

7.  Appropriateness and delay to initiate therapy in ventilator-associated pneumonia.

Authors:  C M Luna; P Aruj; M S Niederman; J Garzón; D Violi; A Prignoni; F Ríos; S Baquero; S Gando
Journal:  Eur Respir J       Date:  2006-01       Impact factor: 16.671

8.  An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients.

Authors:  David M Young; Hobart W Harris; Edwin D Charlebois; Henry Chambers; Andre Campbell; Françoise Perdreau-Remington; Chen Lee; Mahesh Mankani; Robert Mackersie; William P Schecter
Journal:  Arch Surg       Date:  2004-09

9.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.

Authors:  Manuel Iregui; Suzanne Ward; Glenda Sherman; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

10.  Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group.

Authors:  F Alvarez-Lerma
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

View more
  28 in total

1.  Comparison of the microbiology and antibiotic treatment among diabetic and nondiabetic patients hospitalized for cellulitis or cutaneous abscess.

Authors:  Timothy C Jenkins; Bryan C Knepper; S Jason Moore; Carla C Saveli; Sean W Pawlowski; Daniel M Perlman; Bruce D McCollister; William J Burman
Journal:  J Hosp Med       Date:  2014-09-30       Impact factor: 2.960

2.  Identifying patients with acute bacterial skin and skin structure infection who need blood cultures.

Authors:  Giusy Tiseo; Antonino Mazzone; Marco Falcone
Journal:  Intern Emerg Med       Date:  2019-01-01       Impact factor: 3.397

Review 3.  Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.

Authors:  Marco Falcone; Ercole Concia; Massimo Giusti; Antonino Mazzone; Claudio Santini; Stefania Stefani; Francesco Violi
Journal:  Intern Emerg Med       Date:  2016-04-15       Impact factor: 3.397

Review 4.  [Bacterial skin and soft tissue infections].

Authors:  Frank Hanses
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

Review 5.  New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides.

Authors:  Matthew P Crotty; Tamara Krekel; C A Burnham; David J Ritchie
Journal:  J Clin Microbiol       Date:  2016-03-09       Impact factor: 5.948

Review 6.  [Clinical symptoms and therapy of necrotizing skin and soft tissue infections].

Authors:  P Kujath; M Hoffmann; E Schlöricke; L Unger; R Bouchard
Journal:  Chirurg       Date:  2012-11       Impact factor: 0.955

7.  Prevalence and factors associated with wound colonization by Staphylococcus spp. and Staphylococcus aureus in hospitalized patients in inland northeastern Brazil: a cross-sectional study.

Authors:  Gilmara Celli Maia Almeida; Marquiony Marques dos Santos; Nara Grazieli Martins Lima; Thiago André Cidral; Maria Celeste Nunes Melo; Kenio Costa Lima
Journal:  BMC Infect Dis       Date:  2014-06-13       Impact factor: 3.090

8.  Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin.

Authors:  Mu Cheng; Zyta M Ziora; Karl A Hansford; Mark A Blaskovich; Mark S Butler; Matthew A Cooper
Journal:  Org Biomol Chem       Date:  2014-04-28       Impact factor: 3.876

9.  Use of electronic health record data to identify skin and soft tissue infections in primary care settings: a validation study.

Authors:  Pamela J Levine; Miriam R Elman; Ravina Kullar; John M Townes; David T Bearden; Rowena Vilches-Tran; Ian McClellan; Jessina C McGregor
Journal:  BMC Infect Dis       Date:  2013-04-10       Impact factor: 3.090

10.  Antibacterial Treatment of Meticillin-Resistant Staphylococcus Aureus Complicated Skin and Soft Tissue Infections: a Cost and Budget Impact Analysis in Greek Hospitals.

Authors:  Kostas Athanasakis; Ioannis Petrakis; Mark Ollandezos; Christos Tsoulas; Dipen A Patel; Eleftheria Karampli; John Kyriopoulos
Journal:  Infect Dis Ther       Date:  2014-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.